PreciGenome to Exhibit at the AACR Annual Meeting 2025

PreciGenome Booth #2903 at AACR 2025 in Chicago.

We are thrilled to announce that PreciGenome will be participating in the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place from April 25–30, 2025, at the McCormick Place Convention Center in Chicago, Illinois. Join us at Booth #2903 to explore our innovative solutions designed to advance cancer research and precision medicine.

About the AACR Annual Meeting

The AACR Annual Meeting is a premier event that brings together leading scientists, clinicians, healthcare professionals, and patient advocates from around the globe. It serves as a platform to showcase groundbreaking advancements in cancer science and medicine. The meeting spans a wide range of topics, including population science, cancer biology, translational research, clinical studies, survivorship, and advocacy. By uniting the brightest minds in cancer research, this event drives progress toward improved prevention, diagnosis, and treatment of cancer.

This year’s theme, Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact, underscores the importance of collaboration and innovation in addressing one of the most pressing health challenges of our time.

About PreciGenome

At PreciGenome, we are committed to empowering researchers and innovators with cutting-edge tools for nucleic acid and lipid nanoparticle (LNP) research. Based in Silicon Valley, we specialize in advanced microfluidic technologies and high-performance systems that enable precision and scalability in scientific discovery.

Our offerings include:

- LNP Synthesis Instruments: Enabling precise and scalable production of lipid nanoparticles for gene delivery and mRNA therapeutics.

- LNP Formulation Reagents: High-quality materials tailored for reliable LNP preparation.

- Custom & Catalog mRNA Solutions: Supporting diverse applications in academia and industry.

- Digital PCR & qPCR Systems: Providing robust platforms for quantitative analysis of nucleic acids.

- LNP CRO Services: Comprehensive contract research services for nucleic acid delivery systems.

With our proprietary technologies like the NanoGenerator® system, we enable researchers to achieve reproducible results in LNP synthesis with tunable size control and high encapsulation efficiency—essential for applications such as mRNA vaccines and gene therapy.

Visit Us at Booth #2903

We invite attendees to stop by our booth to learn more about how our innovative solutions can accelerate your research goals. Our team will be on-site to provide live demonstrations and discuss how PreciGenome’s technologies can support your work in cancer research and beyond.

Let’s connect at AACR 2025 to explore how we can shape the future of precision medicine together!

For more information about our products and services, visit [precigenome.com](https://www.precigenome.com).

We look forward to seeing you at the AACR Annual Meeting 2025!